Primary Site >> Colorectal Cancer
Gene >> SLC22A5
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
|
Ref: Inflammatory response gene polymorphisms and their relationship with colorectal cancer risk. PMID: 18433468 |
Ref: Association of the OCTN1/1672T variant with increased risk for colorectal cancer in young individuals and ulcerative colitis patients. PMID: 21793125 |
Ref: Luteolin potentiates the sensitivity of colorectal cancer cell lines to oxaliplatin through the PPARgamma/OCTN2 pathway. PMID: 25075794 |
Ref: Acetylcarnitine potentiates the anticarcinogenic effects of butyrate on SW480 colon cancer cells. PMID: 26043725 |
Ref: Phytochemicals Mediate the Expression and Activity of OCTN2 as Activators of the PPARgamma/RXRalpha Pathway. PMID: 27445823 |
Ref: Dual targeting of l-carnitine-conjugated nanoparticles to OCTN2 and ATB(0,+) to deliver chemotherapeutic agents for colon cancer therapy. PMID: 28911246 |
Ref: Integrative expression quantitative trait locus-based analysis of colorectal cancer identified a functional polymorphism regulating SLC22A5 expression. PMID: 29428571 Ref: Ergothioneine ameliorates oxaliplatin-induced peripheral neuropathy in rats. PMID: 29981320 Ref: Identification of drug transporters contributing to oxaliplatin-induced peripheral neuropathy. PMID: 30295925 |